Erratum: Impaired Prefrontal-Basal Ganglia Functional Connectivity and Substantia Nigra Hyperactivity in Schizophrenia (Biological Psychiatry (2013)74(2)(122–129), (S0006322312010062), (10.1016/j.biopsych.2012.11.018));Impaired prefrontal-basal ganglia functional connectivity and substantia nigra hyperactivity in schizophrenia

Biological Psychiatry

Volumn 74, Issue 2, 2013, Pages 122-129

  Yoon, Jong H ^a   Minzenberg, Michael J ^a   Raouf, Sherief ^a   D'Esposito, Mark ^b   Carter, Cameron S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Basal ganglia; fMRI; prefrontal cortex; psychosis; schizophrenia; substantia nigra

Indexed keywords

DOPAMINE;

ADULT; ARTICLE; BASAL GANGLION; BEHAVIOR; BRAIN DYSFUNCTION; BRAIN FUNCTION; CAUDATE NUCLEUS; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DISEASE SEVERITY; EVENT RELATED POTENTIAL; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; MALE; NIGRONEOSTRIATAL SYSTEM; PATHOGENESIS; PREFRONTAL CORTEX; PREFRONTAL CORTEX DYSFUNCTION; PRIORITY JOURNAL; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SUBSTANTIA NIGRA; TASK PERFORMANCE; WORKING MEMORY;

EID: 84879500873     PISSN: 00063223     EISSN: 18732402     Source Type: Journal    
DOI: 10.1016/j.biopsych.2019.04.002     Document Type: Erratum

References (55)

1. A. Abi-Dargham, R. Gil, J. Krystal, R.M. Baldwin, J.P. Seibyl, and M. Bowers Increased striatal dopamine transmission in schizophrenia: Confirmation in a second cohort Am J Psychiatry 155 1998 761 767
2. A. Breier, T.P. Su, R. Saunders, R.E. Carson, B.S. Kolachana, and A. de Bartolomeis Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: Evidence from a novel positron emission tomography method Proc Natl Acad Sci U S A 94 1997 2569 2574
3. L.S. Kegeles, A. Abi-Dargham, W.G. Frankle, R. Gil, T.B. Cooper, and M. Slifstein Increased synaptic dopamine function in associative regions of the striatum in schizophrenia Arch Gen Psychiatry 67 2010 231 239
4. M. Laruelle, A. Abi-Dargham, C.H. van Dyck, R. Gil, C.D. D'Souza, and J. Erdos Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects Proc Natl Acad Sci U S A 93 1996 9235 9240
5. K.F. Berman, R.F. Zec, and D.R. Weinberger Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. II. Role of neuroleptic treatment, attention, and mental effort Arch Gen Psychiatry 43 1986 126 135
6. D.H. Ingvar, and G. Franzen Abnormalities of cerebral blood flow distribution in patients with chronic schizophrenia Acta Psychiatr Scand 50 1974 425 462
7. J.H. Yoon, M.J. Minzenberg, S. Ursu, B.S. Ryan Walter, C. Wendelken, J.D. Ragland, and C.S. Carter Association of dorsolateral prefrontal cortex dysfunction with disrupted coordinated brain activity in schizophrenia: Relationship with impaired cognition, behavioral disorganization, and global function Am J Psychiatry 165 2008 1006 1014
8. D.R. Weinberger Implications of normal brain development for the pathogenesis of schizophrenia Arch Gen Psychiatry 44 1987 660 669
9. C.J. Pycock, R.W. Kerwin, and C.J. Carter Effect of lesion of cortical dopamine terminals on subcortical dopamine receptors in rats Nature 286 1980 74 76
10. T.A. Lesh, T.A. Niendam, M.J. Minzenberg, and C.S. Carter Cognitive control deficits in schizophrenia: Mechanisms and meaning Neuropsychopharmacology 36 2011 316 338
11. A. Bertolino, M.B. Knable, R.C. Saunders, J.H. Callicott, B. Kolachana, and V.S. Mattay The relationship between dorsolateral prefrontal N-acetylaspartate measures and striatal dopamine activity in schizophrenia Biol Psychiatry 45 1999 660 667
12. A. Meyer-Lindenberg, R.S. Miletich, P.D. Kohn, G. Esposito, R.E. Carson, and M. Quarantelli Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophrenia Nat Neurosci 5 2002 267 271
13. A. Björklund, and S. Dunnett Dopamine neuron systems in the brain: An update Trends Neurosci 30 2007 194 202
14. A.A. Grace, and B.S. Bunney Opposing effects of striatonigral feedback pathways on midbrain dopamine cell activity Brain Res 333 1985 271 284
15. C.A. Paladini, P. Celada, and J.M. Tepper Striatal, pallidal, and pars reticulata evoked inhibition of nigrostriatal dopaminergic neurons is mediated by GABA(A) receptors in vivo Neuroscience 89 1999 799 812
16. G.K. Murray, P.R. Corlett, L. Clark, M. Pessiglione, A.D. Blackwell, and G. Honey Substantia nigra/ventral tegmental reward prediction error disruption in psychosis Mol Psychiatry 13 239 2008 267 276
17. L. Romaniuk, G.D. Honey, J.R. King, H.C. Whalley, A.M. McIntosh, and L. Levita Midbrain activation during pavlovian conditioning and delusional symptoms in schizophrenia Arch Gen Psychiatry 67 2010 1246 1254
18. S.M. Landau, R. Lal, J.P. O'Neil, S. Baker, and W.J. Jagust Striatal dopamine and working memory Cereb Cortex 19 2009 445 454
19. S.J. Lewis, A. Dove, T.W. Robbins, R.A. Barker, and A.M. Owen Striatal contributions to working memory: A functional magnetic resonance imaging study in humans Eur J Neurosci 19 2004 755 760
20. M.J. Minzenberg, A.R. Laird, S. Thelen, C.S. Carter, and D.C. Glahn Meta-analysis of 41 functional neuroimaging studies of executive function in schizophrenia Arch Gen Psychiatry 66 2009 811 822
21. D.M. Barch, C.S. Carter, A.W. MacDonald 3rd, T.S. Braver, and J.D. Cohen Context-processing deficits in schizophrenia: Diagnostic specificity, 4-week course, and relationships to clinical symptoms J Abnorm Psychol 112 2003 132 143
22. J.A. Maldjian, P.J. Laurienti, R.A. Kraft, and J.H. Burdette An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets Neuroimage 19 2003 1233 1239
23. J.L. Lancaster, M.G. Woldorff, L.M. Parsons, M. Liotti, C.S. Freitas, and L. Rainey Automated Talairach atlas labels for functional brain mapping Hum Brain Mapp 10 2000 120 131
24. J. Rissman, A. Gazzaley, and M. D'Esposito Measuring functional connectivity during distinct stages of a cognitive task Neuroimage 23 2004 752 763
25. K.J. Friston, A. Holmes, J.B. Poline, C.J. Price, and C.D. Frith Detecting activations in PET and fMRI: Levels of inference and power Neuroimage 4 1996 223 235
26. C.R. Gerfen, W.A. Staines, G.W. Arbuthnott, and H.C. Fibiger Crossed connections of the substantia nigra in the rat J Comp Neurol 207 1982 283 303
27. P.A. Kelly, D.I. Graham, and J. McCulloch Specific alterations in local cerebral glucose utilization following striatal lesions Brain Res 233 1982 157 172
28. J.D. Power, K.A. Barnes, A.Z. Snyder, B.L. Schlaggar, and S.E. Petersen Spurious but systematic correlations in functional connectivity MRI networks arise from subject motion Neuroimage 59 2012 2142 2154
29. T.D. Satterthwaite, D.H. Wolf, J. Loughead, K. Ruparel, M.A. Elliott, and H. Hakonarson Impact of in-scanner head motion on multiple measures of functional connectivity: Relevance for studies of neurodevelopment in youth Neuroimage 60 2012 623 632
30. K.R. Van Dijk, M.R. Sabuncu, and R.L. Buckner The influence of head motion on intrinsic functional connectivity MRI Neuroimage 59 2011 431 438
31. B.H. Schott, L. Minuzzi, R.M. Krebs, D. Elmenhorst, M. Lang, and O.H. Winz Mesolimbic functional magnetic resonance imaging activations during reward anticipation correlate with reward-related ventral striatal dopamine release J Neurosci 28 2008 14311 14319
32. A. Devor, P. Tian, N. Nishimura, I.C. Teng, E.M. Hillman, and S.N. Narayanan Suppressed neuronal activity and concurrent arteriolar vasoconstriction may explain negative blood oxygenation level-dependent signal J Neurosci 27 2007 4452 4459
33. K. Schafer, F. Blankenburg, R. Kupers, J.M. Gruner, I. Law, M. Lauritzen, and H.B. Larsson Negative BOLD signal changes in ipsilateral primary somatosensory cortex are associated with perfusion decreases and behavioral evidence for functional inhibition Neuroimage 59 2012 3119 3127
34. J.H. Lee, R. Durand, V. Gradinaru, F. Zhang, I. Goshen, and D.S. Kim Global and local fMRI signals driven by neurons defined optogenetically by type and wiring Nature 465 2010 788 792
35. N.K. Logothetis, J. Pauls, M. Augath, T. Trinath, and A. Oeltermann Neurophysiological investigation of the basis of the fMRI signal Nature 412 2001 150 157
36. R. Mukamel, H. Gelbard, A. Arieli, U. Hasson, I. Fried, and R. Malach Coupling between neuronal firing, field potentials, and FMRI in human auditory cortex Science 309 2005 951 954
37. S.N. Haber, J.L. Fudge, and N.R. McFarland Striatonigrostriatal pathways in primates form an ascending spiral from the shell to the dorsolateral striatum J Neurosci 20 2000 2369 2382
38. J.M. Lappin, S.J. Reeves, M.A. Mehta, A. Egerton, M. Coulson, and P.M. Grasby Dopamine release in the human striatum: Motor and cognitive tasks revisited J Cereb Blood Flow Metab 29 2009 554 564
39. A. Bertolino, A. Breier, J.H. Callicott, C. Adler, V.S. Mattay, and M. Shapiro The relationship between dorsolateral prefrontal neuronal N-acetylaspartate and evoked release of striatal dopamine in schizophrenia Neuropsychopharmacology 22 2000 125 132
40. W. Frankle, M. Laruelle, and S. Haber Prefrontal cortical projections to the midbrain in primates: Evidence for a sparse connection Neuropsychopharmacology 31 2006 1627 1636
41. N. Chuhma, K.F. Tanaka, R. Hen, and S. Rayport Functional connectome of the striatal medium spiny neuron J Neurosci 31 2011 1183 1192
42. A. Carlsson, and M. Lindqvist Effect of chlorpromazine or haloperidol on formation of 3methoxytyramine and normetanephrine in mouse brain Acta Pharmacol Toxicol (Copenh) 20 1963 140 144
43. P. Seeman, M. Chau-Wong, J. Tedesco, and K. Wong Brain receptors for antipsychotic drugs and dopamine: Direct binding assays Proc Natl Acad Sci U S A 72 1975 4376 4380
44. L. Farde, F.A. Wiesel, C. Halldin, and G. Sedvall Central D2-dopamine receptor occupancy in schizophrenic patients treated with antipsychotic drugs Arch Gen Psychiatry 45 1988 71 76
45. S. Kapur, R. Zipursky, C. Jones, G. Remington, and S. Houle Relationship between dopamine D(2) occupancy, clinical response, and side effects: A double-blind PET study of first-episode schizophrenia Am J Psychiatry 157 2000 514 520
46. A.L. Nordstrom, L. Farde, F.A. Wiesel, K. Forslund, S. Pauli, C. Halldin, and G. Uppfeldt Central D2-dopamine receptor occupancy in relation to antipsychotic drug effects: A double-blind PET study of schizophrenic patients Biol Psychiatry 33 1993 227 235
47. J.M. Gold, J.A. Waltz, T.M. Matveeva, Z. Kasanova, G.P. Strauss, and E.S. Herbener Negative symptoms and the failure to represent the expected reward value of actions: Behavioral and computational modeling evidence Arch Gen Psychiatry 69 2012 129 138
48. I. Feinberg Schizophrenia: Caused by a fault in programmed synaptic elimination during adolescence? J Psychiatr Res 17 1982 319 334
49. C. Kellendonk, E.H. Simpson, H.J. Polan, G. Malleret, S. Vronskaya, and V. Winiger Transient and selective overexpression of dopamine D2 receptors in the striatum causes persistent abnormalities in prefrontal cortex functioning Neuron 49 2006 603 615
50. A. Abi-Dargham, O. Mawlawi, I. Lombardo, R. Gil, D. Martinez, and Y. Huang Prefrontal dopamine D1 receptors and working memory in schizophrenia J Neurosci 22 2002 3708 3719
51. D. Durstewitz, and J.K. Seamans The dual-state theory of prefrontal cortex dopamine function with relevance to catechol-o-methyltransferase genotypes and schizophrenia Biol Psychiatry 64 2008 739 749
52. G. Winterer, and D.R. Weinberger Genes, dopamine and cortical signal-to-noise ratio in schizophrenia Trends Neurosci 27 2004 683 690
53. K.L. Davis, R.S. Kahn, G. Ko, and M. Davidson Dopamine in schizophrenia: A review and reconceptualization Am J Psychiatry 148 1991 1474 1486
54. S.N. Haber, J.L. Fudge, and N.R. McFarland Striatonigrostriatal pathways in primates form an ascending spiral from the shell to the dorsolateral striatum J Neurosci 20 2000 2369 2382
55. S.M. Williams, and P.S. Goldman-Rakic Widespread origin of the primate mesofrontal dopamine system Cereb Cortex 8 1998 321 345